NPY and kidney failure: Neuropeptide Y (NPY), a sympathetic neurotransmitter, has been shown to be associated with proteinuria and faster progression of Chronic Kidney Disease (CKD), as well as with a higher risk of kidney failure, suggesting that the sympathetic system via this mechanism may play a role in organ damage and CKD progression (Zoccali et al., 2018).